Steven A. Lisi is recorded as Board Member at Beyond Air, Inc. (XAIR) since November 22, 2024. Beyond Air, Inc. reported in an 8-K filed April 1, 2026 that Steven A. Lisi resigned as Director of the Board, effective March 27, 2026. Beyond Air, Inc. reported in an 8-K filed April 1, 2026 that Steven A. Lisi resigned as Chief Executive Officer, effective March 27, 2026. Beyond Air, Inc. reported in an 8-K filed November 26, 2024 that Steven A. Lisi was appointed Director, effective November 22, 2024. Equibles holds 5 filed executive changes naming Steven A. Lisi; each is listed under recent activity with its source filing. The proxy statement of Beyond Air, Inc. reports total compensation of $9,392,800 for Steven A. Lisi in fiscal 2022, including a base salary of $450,000. Disclosed compensation is on record for 4 fiscal years. Steven A. Lisi has spoken on 1 earnings call across 1 company, most recently for Beyond Air, Inc. on November 14, 2025. Beyond Air, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Beyond Air, Inc. includes Robert Goodman (CEO and Board Member), Robert S. Goodman (CEO and Board Member), Robert F. Carey (Chairman) and 7 others.
“On March 26, 2026, Mr. Steven A. Lisi notified the board of directors ("Board") of Beyond Air, Inc. ("Beyond Air" or the "Company") of his resignation as the Company's Chief Executive Officer ("CEO") and as Director of the Board and from all his positions with the Company and its subsidiaries, effective March 27, 2026.”
Beyond Air, Inc. Form 8-K, filed April 1, 2026
· Read the filing
“On March 26, 2026, Mr. Steven A. Lisi notified the board of directors ("Board") of Beyond Air, Inc. ("Beyond Air" or the "Company") of his resignation as the Company's Chief Executive Officer ("CEO") and as Director of the Board and from all his positions with the Company and its subsidiaries, effective March 27, 2026.”
Beyond Air, Inc. Form 8-K, filed April 1, 2026
· Read the filing
Steven A. Lisi on recent calls
“With me here today is Doug Larson, our Chief Financial Officer. We continue to receive highly encouraging feedback from hospitals using LungFit PH, reinforcing the clinical value and operational efficiency our technology delivers.”
